Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival.

G Vairo, KM Innes, JM Adams - Oncogene, 1996 - europepmc.org
G Vairo, KM Innes, JM Adams
Oncogene, 1996europepmc.org
Myeloid maturation appears to require exit from the cell cycle and leads to activation of
apoptosis in the differentiated cells. The level of Bcl-2, which is known to promote cell
survival, is shown here to influence both these critical steps. Bcl-2 function during
myelomonocytic differentiation was investigated by introducing a deregulated bcl-2 gene
into HL60 promyelocytic leukemia cells, which can be induced to exit the cell cycle and
differentiate into granulocytes or monocytes. Deregulated Bcl-2 expression did not itself …
Myeloid maturation appears to require exit from the cell cycle and leads to activation of apoptosis in the differentiated cells. The level of Bcl-2, which is known to promote cell survival, is shown here to influence both these critical steps. Bcl-2 function during myelomonocytic differentiation was investigated by introducing a deregulated bcl-2 gene into HL60 promyelocytic leukemia cells, which can be induced to exit the cell cycle and differentiate into granulocytes or monocytes. Deregulated Bcl-2 expression did not itself promote differentiation but extended the lifespan of mature cells elicited by granulocytic or monocytic inducers. Unexpectedly, in response to induction, Bcl-2 overexpression markedly potentiated and hastened cell cycle withdrawal into G (0). Enhanced survival cannot account for the elevated numbers of G (0) cells, because they arose under induction conditions that did not kill control cells. Since the cell cycle status and growth of uninduced cells was not affected by Bcl-2-overexpression, its cell cycle inhibitory activity must require an induction signal. While cell cycle withdrawal may be necessary for maturation, it was not sufficient, implicating a requirement for specific differentiative signals. These results identify, for the first time, a function for the bcl-2 proto-oncogene that is separable from its enhancement of cell survival.
europepmc.org